Leyden Laboratories
Develops antibody-based nasal sprays intended to prevent influenza and other respiratory-virus infections.
€40MSeries B
Role not disclosedI
Invest-NL
Activity from announced rounds
Activity in this selectionOct 24, 2026 · Enterprise software · Jan 1, 2026
- Rounds participated in
- 3
- Confirmed lead rounds
- — 3 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $675.4M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionNearfield Instruments
Develops advanced 3D scanning probe metrology and inspection systems for semiconductor manufacturing
$380MSeries D
Role not disclosedAxelera AI
Develops AI acceleration hardware for edge computing and data center applications
$250MGrowth
Role not disclosed